List of insiders holdings for CalciMedica Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. DEERFIELD PARTNERS L.P. *Possible Member of 10% Group 10% Owner |
2024-02-01 17:29:56 | 2,613,012 0 |
2,613,012 | Form 13G |
| 2 | Sanderling Venture Partners VI Co Investment Fund LP Sanderling Ventures Management VI Sanderling VI Beteiligungs GmbH & Co KG Sanderling Venture Partners VI LP Sanderling VI Limited Partnership Sanderling Ventures VII L.P. Sanderling Ventures VII (Canada) L.P. Sanderling Ventures VII Annex Fund L.P. Sanderling Ventures Management VII 10% Owner |
2024-11-26 06:03:55 | 2,550,550 0 |
2,550,550 | Form 13D |
| 3 | MIDDLETON FRED A Director 10% Owner |
2024-12-06 19:12:27 | 36,514 2,415,348 |
2,451,862 | Form 4 |
| 4 | Valence Investments SPV IV LLC Valence Investments SPV V LLC Valence Investments SPV VI LLC 10% Owner |
2024-11-06 16:17:55 | 1,217,678 0 |
1,217,678 | Form 13D |
| 5 | Keyoung Hansoo Michael Director |
2020-09-29 16:40:20 | 0 1,133,596 |
1,133,596 | Form 4 |
| 6 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER 10% Owner |
2024-11-01 13:25:51 | 130,926 740,326 |
871,252 | Form 4 |
| 7 | WILSON ROBERT N Director |
2024-11-01 13:22:06 | 417,529 0 |
417,529 | Form 4 |
| 8 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
2024-02-05 16:48:48 | 297,380 0 |
297,380 | Form 13D |
| 9 | Bardin Stephen Chief Financial Officer |
2024-11-15 16:04:55 | 145,000 0 |
145,000 | Form 3 |
| 10 | Hebbar Sudarshan Chief Medical Officer |
2024-08-28 19:09:00 | 82,500 0 |
82,500 | Form 4 |
| 11 | Stauderman Kenneth A. Chief Scientific Officer |
2024-08-28 19:10:49 | 62,500 0 |
62,500 | Form 4 |
| 12 | BREUIL ROBERT S Chief Financial Officer |
2023-03-27 19:56:09 | 35,326 0 |
35,326 | Form 4 |
| 13 | Salain Daniel CTOO |
2020-12-10 17:10:59 | 35,000 0 |
35,000 | Form 4 |
| 14 | Zamiri Parisa Chief Medical Officer |
2023-03-27 19:59:47 | 28,982 0 |
28,982 | Form 4 |
| 15 | Glicklich Alan Director |
2025-01-16 19:51:03 | 20,000 0 |
20,000 | Form 4 |
| 16 | Cagle Gerald D. Director |
2021-06-04 18:37:44 | 12,500 0 |
12,500 | Form 4 |
| 17 | Dunn Michael J. President and COO |
2024-09-11 17:00:06 | 11,761 0 |
11,761 | Form 4 |
| 18 | Geffken Daniel E. Interim CFO |
2024-05-20 19:47:02 | 0 10,000 |
10,000 | Form 4 |
| 19 | Shaw Allan Director |
2024-08-28 19:13:34 | 10,000 0 |
10,000 | Form 4 |
| 20 | BJERKHOLT ERIC Director |
2024-08-28 19:14:14 | 10,000 0 |
10,000 | Form 4 |
| 21 | Guerard Frederic Director |
2024-08-28 19:14:57 | 10,000 0 |
10,000 | Form 4 |
| 22 | Roberts Eric W CHIEF BUSINESS OFFICER 10% Owner |
2024-11-06 20:00:07 | 0 3,000 |
3,000 | Form 4/A |
| 23 | SHAFFER CHRISTY L Director |
2023-03-27 19:59:08 | 1,429 0 |
1,429 | Form 4 |
| 24 | Sauer Dirk Director |
2023-03-27 19:58:21 | 1,429 0 |
1,429 | Form 4 |
| 25 | EASTLAND JULIA MARIE Director |
2023-03-27 19:57:01 | 1,429 0 |
1,429 | Form 4 |
| 26 | ACKERMANN CHRISTINA Director |
2023-03-27 19:54:44 | 1,429 0 |
1,429 | Form 4 |
| 27 | Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. Blackstone Clarus III L.L.C. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner |
2022-02-11 06:40:04 | 0 0 |
0 | Form 13G |